GB-1874

N/A

Report date: 2025/01/26 19:02:25

NME

Base Information

Drug NameGB-1874

Drug Alias NameWnt signaling inhibitor (National Cancer Centre of Singapore/Agency For Science Technology and Research)beta-catenin/TCF4 interaction inhibitor (National Cancer Centre of Singapore/Agency For Science Technology and Research)GB-1874

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCatenin beta 1 degraders

TargetsCatenin beta 1

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNational Cancer Centre Singapore

China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Centre Singapore The Agency for Science Technology and Research

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A